Ad is loading...
ENSC
Price
$8.19
Change
+$0.95 (+13.12%)
Updated
Dec 6 closing price
GNPX
Price
$1.04
Change
-$0.04 (-3.70%)
Updated
Dec 6 closing price
Ad is loading...

ENSC vs GNPX

Header iconENSC vs GNPX Comparison
Open Charts ENSC vs GNPXBanner chart's image
Ensysce Biosciences
Price$8.19
Change+$0.95 (+13.12%)
Volume$227.6K
CapitalizationN/A
Genprex
Price$1.04
Change-$0.04 (-3.70%)
Volume$556.18K
CapitalizationN/A
ENSC vs GNPX Comparison Chart
Loading...
ENSC
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
GNPX
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
View a ticker or compare two or three
VS
ENSC vs. GNPX commentary
Dec 09, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ENSC is a StrongBuy and GNPX is a StrongSell.

COMPARISON
Comparison
Dec 09, 2024
Stock price -- (ENSC: $8.19 vs. GNPX: $1.04)
Brand notoriety: ENSC and GNPX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ENSC: 9% vs. GNPX: 4%
Market capitalization -- ENSC: $9.45M vs. GNPX: $9.19M
ENSC [@Biotechnology] is valued at $9.45M. GNPX’s [@Biotechnology] market capitalization is $9.19M. The market cap for tickers in the [@Biotechnology] industry ranges from $489.7B to $0. The average market capitalization across the [@Biotechnology] industry is $2.71B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ENSC’s FA Score shows that 0 FA rating(s) are green whileGNPX’s FA Score has 0 green FA rating(s).

  • ENSC’s FA Score: 0 green, 5 red.
  • GNPX’s FA Score: 0 green, 5 red.
According to our system of comparison, ENSC is a better buy in the long-term than GNPX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ENSC’s TA Score shows that 5 TA indicator(s) are bullish while GNPX’s TA Score has 2 bullish TA indicator(s).

  • ENSC’s TA Score: 5 bullish, 4 bearish.
  • GNPX’s TA Score: 2 bullish, 6 bearish.
According to our system of comparison, ENSC is a better buy in the short-term than GNPX.

Price Growth

ENSC (@Biotechnology) experienced а +10.55% price change this week, while GNPX (@Biotechnology) price change was -4.59% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -1.01%. For the same industry, the average monthly price growth was -2.68%, and the average quarterly price growth was +10.76%.

Reported Earning Dates

ENSC is expected to report earnings on May 15, 2023.

GNPX is expected to report earnings on May 29, 2024.

Industries' Descriptions

@Biotechnology (-1.01% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ENSC($9.45M) and GNPX($9.19M) have the same market capitalization . ENSC YTD gains are higher at: -48.491 vs. GNPX (-88.696). GNPX has less debt than ENSC: GNPX (279K) vs ENSC (387K).
ENSCGNPXENSC / GNPX
Capitalization9.45M9.19M103%
EBITDAN/A-22.82M-
Gain YTD-48.491-88.69655%
P/E RatioN/AN/A-
RevenueN/A0-
Total CashN/A1.49M-
Total Debt387K279K139%
FUNDAMENTALS RATINGS
ENSC vs GNPX: Fundamental Ratings
ENSC
GNPX
OUTLOOK RATING
1..100
9746
VALUATION
overvalued / fair valued / undervalued
1..100
41
Fair valued
54
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
99100
PRICE GROWTH RATING
1..100
5061
P/E GROWTH RATING
1..100
99100
SEASONALITY SCORE
1..100
8595

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

ENSC's Valuation (41) in the null industry is in the same range as GNPX (54) in the Pharmaceuticals Major industry. This means that ENSC’s stock grew similarly to GNPX’s over the last 12 months.

ENSC's Profit vs Risk Rating (100) in the null industry is in the same range as GNPX (100) in the Pharmaceuticals Major industry. This means that ENSC’s stock grew similarly to GNPX’s over the last 12 months.

ENSC's SMR Rating (99) in the null industry is in the same range as GNPX (100) in the Pharmaceuticals Major industry. This means that ENSC’s stock grew similarly to GNPX’s over the last 12 months.

ENSC's Price Growth Rating (50) in the null industry is in the same range as GNPX (61) in the Pharmaceuticals Major industry. This means that ENSC’s stock grew similarly to GNPX’s over the last 12 months.

ENSC's P/E Growth Rating (99) in the null industry is in the same range as GNPX (100) in the Pharmaceuticals Major industry. This means that ENSC’s stock grew similarly to GNPX’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ENSCGNPX
RSI
ODDS (%)
Bearish Trend 4 days ago
86%
N/A
Stochastic
ODDS (%)
Bullish Trend 3 days ago
76%
Bullish Trend 3 days ago
75%
Momentum
ODDS (%)
Bearish Trend 3 days ago
79%
Bearish Trend 3 days ago
90%
MACD
ODDS (%)
Bearish Trend 3 days ago
80%
Bearish Trend 3 days ago
90%
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
73%
Bearish Trend 3 days ago
90%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
72%
Bearish Trend 3 days ago
90%
Advances
ODDS (%)
Bullish Trend 13 days ago
78%
Bullish Trend 7 days ago
80%
Declines
ODDS (%)
Bearish Trend 4 days ago
90%
Bearish Trend 5 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 3 days ago
83%
N/A
Aroon
ODDS (%)
Bullish Trend 3 days ago
75%
Bearish Trend 3 days ago
90%
View a ticker or compare two or three
Ad is loading...
ENSC
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
GNPX
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
RVSN0.440.01
+1.96%
Rail Vision Ltd
BSY49.740.18
+0.36%
Bentley Systems
PVBC11.55-0.09
-0.77%
Provident Bancorp
TFPM16.27-0.42
-2.52%
Triple Flag Precious Metals Corp
STGW7.62-0.26
-3.30%
Stagwell